DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/qgxb92/us_haemophilia_b) has announced the addition of the "US Haemophilia B Market Highlights - 2014" report to their offering.
The latest research, 'US Haemophilia B Market Highlights - 2014', provides the US haemophilia B market analysis, competitive landscape, and haemophilia B drug sales forecast in the US.
The research includes the US haemophilia B market size estimates for 2013, market share forecast for six years to 2019, haemophilia B drugs market share, haemophilia B drugs sales estimates, haemophilia B drugs sales forecast, and haemophilia B late stage pipeline products.
This research helps executives track competitor drugs sales and market share in the US haemophilia B market. It supports decision making in R&D to long term marketing strategies. The report can be used for evaluating business opportunities, formulating business development strategies, and product positioning in the US haemophilia B market.
Highlights of the Research:
- Marketed Haemophilia B Drugs in the US
- The US Haemophilia B Market Analysis
- Haemophilia B Drugs Sales Analysis in the US
- Competitive Landscape in the US Haemophilia B market
- Haemophilia B Late Stage Pipeline
- The US Haemophilia B Market Forecast
- Haemophilia B Drugs Sales Forecast in the US
- Future Competitive Landscape
Key Topics Covered:
1. Haemophilia B - Disease Definition
2. Marketed Haemophilia B Drugs in US
3. US Haemophilia B Market Analysis
4. Competitive Landscape in US Haemophilia B Market
5. US Haemophilia B Market - Future Market Outlook
For more information visit http://www.researchandmarkets.com/research/qgxb92/us_haemophilia_b